Zhengxing Zeng

Recombinant Super-Compound Interferon (rSIFN-co) Versus Interferon Alfa in the Treatment of Moderate-to-Severe COVID-19: A Multicentre, Randomised, Phase 2 Trial

Zheng-Yang Shi, N. Xiong, F. Luo, 2020 .

Effect of a genetically engineered interferon-alpha versus traditional interferon-alpha in the treatment of moderate-to-severe COVID-19: a randomised clinical trial

Zheng-Yang Shi, N. Xiong, Wei-min Li, 2021, Annals of medicine.

Engineered interferon alpha effectively improves clinical outcomes of COVID-19 patients

Dan Liu, Zheng-Yang Shi, N. Xiong, 2020 .

Identifies Immune Feature Genes for Prediction of Chemotherapy Benefit in Cancer

Yulan Deng, Senyi Deng, L. Xia, 2022, Journal of Cancer.

Synthesis, biological activities and docking study of novel chalcone-pleuromutilin derivatives.

Wei Zhang, Qian Zhang, Tian-Ye Chen, 2020, Chemical biology & drug design.

Assessment of genetic polymorphisms within nuclear factor-κB signaling pathway genes in rheumatoid arthritis: Evidence for replication and genetic interaction.

Wei Zhang, H. Cen, Ting-Hui Wang, 2021, International Immunopharmacology.